相关的药理动力学,生物可用性和生物等价性研究胺酸 (各种物种):一篇综述
César Alas-Pineda1, Dennis J Pavón-Varela1, Kristhel Gaitán-Zambrano1
1Department of Research & Development, Moxie Health Group, Florida, FL, United States.
Frontiers in pharmacology
|December 29, 2025
概括
非尼拉胺酸 (CPM) 的药理动力学和生物可用性在物种之间尚不清楚. 本综述强调了配方变异性,并探索了改善药物输送的鼻内/口腔途径.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物运输 药物运输 药物运输
- 翻译科学 翻译科学
背景情况:
- 非尼拉胺酸 (CPM) 是一种广泛用于过敏的抗组胺药物.
- 其物种间的药理动力学 (PK) 和生物可用性概况并未得到很好的描述.
- 了解物种间的变异性对于药物开发和新型配方至关重要.
研究的目的:
- 总结和评估CPM的药理动力学,生物可用性和物种特异性行为.
- 调查机械洞察力和配方依赖的变性.
- 强调鼻内和口腔给药途径及其转化潜力.
主要方法:
- 根据PRISMA-ScR 2018指南进行了范围审查.
- 通过PubMed搜索确定了评估人类和动物模型中CPM药理动学的研究.
- 总共分析了13项相关研究.
主要成果:
- CPM表现出中度的口服生物利用率 (25%-50%) 和广泛的组织分布,半衰期长 (~20小时).
- 鼻内和口腔途径提供更快的吸收和部分肝绕道.
- 生物等价性研究表明,有显著的配方依赖的变化.
结论:
- CPM是一种有价值的药物,其输送途径和应用尚未得到充分探索.
- 需要对配方的标准化和进一步的试验来优化治疗潜力.
- 人群特异性药理动力学需要进一步研究.
相关概念视频
Bioavailability Study Design: Single Versus Multiple Dose Studies
176
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
176
Bioavailability Study Design: Healthy Subjects Versus Patients
130
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
130
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
598
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
598
Bioavailability Study Design: Absolute Versus Relative Bioavailability
267
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
267
Measurement of Bioavailability: Pharmacokinetic Methods
232
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
232
Bioequivalence Data: Statistical Interpretation
179
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
179


